ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Recordati to acquire EUSA Pharma to expand rare disease products portfolio
December 06, 2021Italian company Recordati has signed an agreement to acquire EUSA Pharma in a deal worth about $848.9m (€750m) to expand its rare disease products portfolio. -
SMC endorses EUSA Pharma’s Qarziba
November 14, 2018A medicine used to treat a rare cancer that predominantly occurs in very young children is to be routinely funded on the NHS in Scotland. -
NICE backs Qarziba for children with high-risk neuroblastoma
July 16, 2018NHS funding for EUSA’s Pharma’s Qarziba has been approved to treat children with high-risk neuroblastoma. -
Long-term benefit of Qarziba uncertain, says NICE
May 07, 2018The National Institute for Health and Care Excellence has ruled against the provision of NHS funding for EUSA Pharma’s neuroblastoma treatment Qarziba.
Pharma Sources Insight January 2025
